Press release
Compounding Chemotherapy Market to Reach USD 1.65 Billion by 2034
Compounding Chemotherapy
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50043
Key Takeaways
• Market Size (2024): USD 1.1 Billion
• Forecast (2034): USD 1.65 Billion
• CAGR (2025 - 2034): 4.2 %
• Leading Companies: Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Omnicell Inc., Grifols S.A., Capsa Healthcare, ARxIUM Inc., Equashield LLC, and Terumo Corporation.
• Core Segments: Cytotoxic Drug Compounding | Non-Cytotoxic Antineoplastic Preparations | Aseptic Automation | Pharmacy Clean-Room Infrastructure.
Market Story
With cancer cases rising globally, hospitals and oncology centers are increasing investment in safe and efficient sterile-compounding environments. Automated compounding robots, dose-tracking software, and closed-system transfer devices (CSTDs) are becoming standard to minimize occupational exposure and ensure precision dosing.
Demand for individualized chemotherapy admixtures-tailored to patient body surface area, toxicity profile, and treatment regimen-is also expanding, particularly across North America and Europe. Meanwhile, developing regions are adopting outsourced oncology compounding services to manage growing patient volumes while meeting stringent regulatory standards.
Market Segmentation
• By Type: Cytotoxic Compounding | Non-Cytotoxic Compounding | Nutritional Support Admixtures | Others
• By End User: Hospital Pharmacies | Oncology Centers | Outsourced Compounding Facilities | Academic Research Institutions
• By Technology: Manual Compounding | Semi-Automated Systems | Fully Automated Robotic Compounding
• By Region:
o North America: Largest market driven by USP / compliance and CSTD integration.
o Europe: Rapid adoption of robotic pharmacy solutions for hazardous drug handling.
o Asia Pacific: Fastest growth due to rising cancer burden and expanding oncology infrastructure in India and China.
o Latin America & MEA: Increasing outsourcing of sterile drug compounding and government investments in hospital modernization.
Explore Full Report here: https://exactitudeconsultancy.com/reports/50043/compounding-chemotherapy-market
Recent Developments
• 2025: Baxter introduced a robotic drug-compounding system to enhance sterility and reduce waste in hospital pharmacies.
• 2024: B. Braun launched its ClinMix Pro solution integrating AI-based dose verification for cytotoxic agents.
• 2023: ICU Medical expanded its ChemoLock portfolio to meet ISO standards for closed drug transfer systems.
• 2022: Omnicell acquired ARxIUM to enhance its automation capabilities in oncology compounding.
Expert Quote
"Automation and precision have become the cornerstones of modern chemotherapy compounding. As oncology care moves toward personalized dosing and safer handling, pharmacies must integrate data-driven systems that ensure accuracy and compliance," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50043
Market Drivers
1. Rising Global Cancer Prevalence and Complex Chemotherapy Regimens.
2. Increased Adoption of Robotic and CSTD Technologies.
3. Regulatory Focus on USP / Sterile Standards and Occupational Safety.
4. Growing Demand for Personalized Medication Preparation in Oncology.
Forecast Outlook
Between 2025 and 2034, the industry will see a surge in AI-enabled dose validation, data integration with EHR systems, and modular clean-room facilities. Service providers offering end-to-end automation and regulatory support will dominate future contract compounding landscapes.
Conclusion
The Compounding Chemotherapy Market is poised for steady expansion as healthcare systems prioritize precision, safety, and automation. With continued technological innovation and regulatory alignment, the sector will play a critical role in advancing safe and personalized oncology care worldwide.
This report is also available in the following languages : Japanese (複合化学療法市場), Korean (복합 화학 요법 시장), Chinese (复合化疗市场), French (Marché de la chimiothérapie composée), German (Markt für die Herstellung von Chemotherapie-Mischungen), and Italian (Mercato della chemioterapia composta), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50043/compounding-chemotherapy-market#request-a-sample
Related Reports
Peritoneal Carcinomatosis (PC) Market
https://exactitudeconsultancy.com/reports/71611/peritoneal-carcinomatosis-pc-market
Head and neck squamous cell carcinomas (HNSCCs) Patient Pool Market
https://exactitudeconsultancy.com/reports/71640/head-and-neck-squamous-cell-carcinomas-hnsccs-patient-pool-market
Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease Market
https://exactitudeconsultancy.com/reports/71962/epstein-barr-virus-associated-post-transplant-lymphoproliferative-disease-market
Chemotherapy-induced Nausea and Vomiting Market
https://exactitudeconsultancy.com/reports/72895/chemotherapy-induced-nausea-and-vomiting-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Chemotherapy Market to Reach USD 1.65 Billion by 2034 here
News-ID: 4266746 • Views: …
More Releases from Exactitude Consultancy
Data Analysis and Storage Management Market to Reach USD 65.7 Billion by 2034
Pune, India, November 11, 2025 - The global Data Analysis and Storage Management Market is expected to expand from USD 34.5 billion in 2024 to USD 65.7 billion by 2034, registering a CAGR of 6.5 %, according to Exactitude Consultancy. With data volumes doubling every two years, enterprises are rapidly adopting AI-enhanced analytics platforms, hybrid storage architectures, and cloud-native management tools to ensure speed, scalability, and security.
Download Full PDF Sample…
HbA1c Testing Market to Reach USD 3.4 Billion by 2034
Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the Global HbA1c Testing Market is valued at USD 2.2 billion in 2024 and is projected to reach USD 3.4 billion by 2034, growing at a CAGR of 4.4% from 2025 to 2034. The market is witnessing robust growth due to increasing diabetes cases, technological advancements in testing devices, and the growing adoption of rapid and point-of-care…
Remdesivir Market to Reach USD 2.1 Billion by 2034
Pune, India, November 11, 2025 - The global Remdesivir Market is projected to expand from USD 1.3 billion in 2024 to USD 2.1 billion by 2034, registering a CAGR of 4.9 %, according to Exactitude Consultancy. Although initially propelled by the COVID-19 pandemic, the market is now stabilizing as governments and healthcare systems maintain strategic antiviral reserves, and manufacturers reposition remdesivir for broader RNA-virus and pandemic-preparedness applications.
Download Full PDF Sample…
Hydroxychloroquine Market to Reach USD 2.9 Billion by 2034
Pune, India, November 11, 2025 - The global Hydroxychloroquine Market is projected to grow from USD 1.8 billion in 2024 to USD 2.9 billion by 2034, exhibiting a CAGR of 4.8 %, according to Exactitude Consultancy. Rising prevalence of autoimmune diseases such as lupus and rheumatoid arthritis, increasing accessibility of generics, and stable demand from malaria-endemic regions are key factors fueling this market expansion.
Download Full PDF Sample Copy of Market…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
